1241 related articles for article (PubMed ID: 20492708)
1. Beta-thalassemia.
Galanello R; Origa R
Orphanet J Rare Dis; 2010 May; 5():11. PubMed ID: 20492708
[TBL] [Abstract][Full Text] [Related]
2. Alpha- and Beta-thalassemia: Rapid Evidence Review.
Baird DC; Batten SH; Sparks SK
Am Fam Physician; 2022 Mar; 105(3):272-280. PubMed ID: 35289581
[TBL] [Abstract][Full Text] [Related]
3. Beta-thalassemia.
Cao A; Galanello R
Genet Med; 2010 Feb; 12(2):61-76. PubMed ID: 20098328
[TBL] [Abstract][Full Text] [Related]
4. New strategies in the treatment of the thalassemias.
Schrier SL; Angelucci E
Annu Rev Med; 2005; 56():157-71. PubMed ID: 15660507
[TBL] [Abstract][Full Text] [Related]
5. Alpha and beta thalassemia.
Muncie HL; Campbell J
Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
[TBL] [Abstract][Full Text] [Related]
6. β-Thalassemia intermedia: a comprehensive overview and novel approaches.
Asadov C; Alimirzoeva Z; Mammadova T; Aliyeva G; Gafarova S; Mammadov J
Int J Hematol; 2018 Jul; 108(1):5-21. PubMed ID: 29380178
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for diagnosis and management of Beta-thalassemia intermedia.
Karimi M; Cohan N; De Sanctis V; Mallat NS; Taher A
Pediatr Hematol Oncol; 2014 Oct; 31(7):583-96. PubMed ID: 25247665
[TBL] [Abstract][Full Text] [Related]
8. Current status of beta-thalassemia and its treatment strategies.
Ali S; Mumtaz S; Shakir HA; Khan M; Tahir HM; Mumtaz S; Mughal TA; Hassan A; Kazmi SAR; Sadia ; Irfan M; Khan MA
Mol Genet Genomic Med; 2021 Dec; 9(12):e1788. PubMed ID: 34738740
[TBL] [Abstract][Full Text] [Related]
9. Thalassemia intermedia: revisited.
Taher A; Isma'eel H; Cappellini MD
Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
[TBL] [Abstract][Full Text] [Related]
10. Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content.
Yassin MA; Soliman AT; De Sanctis V; Yassin KS; Abdulla MA
Mediterr J Hematol Infect Dis; 2019; 11(1):e2019026. PubMed ID: 31205630
[TBL] [Abstract][Full Text] [Related]
11. [Clinical management of beta-thalassaemia].
Thuret I
Rev Prat; 2014 Oct; 64(8):1132-7. PubMed ID: 25510144
[TBL] [Abstract][Full Text] [Related]
12. Insight onto the pathophysiology and clinical complications of thalassemia intermedia.
Cappellini MD; Musallam KM; Taher AT
Hemoglobin; 2009; 33 Suppl 1():S145-59. PubMed ID: 20001620
[TBL] [Abstract][Full Text] [Related]
13. [Current management of thalassemia intermedia].
Thuret I
Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
[TBL] [Abstract][Full Text] [Related]
14. Thalassemia.
Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]